Thromboxane-A Synthase, antagonists & inhibitors

Name
Thromboxane-A Synthase, antagonists & inhibitors
Accession Number
DBCAT001297
Description
Not Available
Drugs
DrugDrug Description
RidogrelUsed as an adjunctive therapy to induce thrombolysis in patients suffering acute myocardial infarction.
DazoxibenNot Available
ImidazoleNot Available
OzagrelOzagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Drugs & Drug Targets
DrugTargetType
RidogrelThromboxane-A synthasetarget
RidogrelThromboxane A2 receptortarget
DazoxibenThromboxane-A synthasetarget
ImidazoleMonomeric sarcosine oxidasetarget
ImidazoleNicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferasetarget
ImidazoleMyoglobintarget
ImidazoleNitric oxide synthase, inducibletarget
ImidazoleAdenylate kinase 2, mitochondrialtarget
ImidazoleSerine/threonine-protein kinase pim-1target
ImidazoleIsopentenyl-diphosphate Delta-isomerasetarget
ImidazoleAlpha,alpha-trehalose-phosphate synthase [UDP-forming]target
ImidazoleLeukotriene A-4 hydrolasetarget
ImidazoleGephyrintarget
ImidazoleAcyl carrier proteintarget
ImidazoleSensor protein FixLtarget
ImidazoleCytochrome ctarget
ImidazoleCircadian clock protein KaiBtarget
ImidazoleHistidinol dehydrogenasetarget
ImidazoleAcyl-CoA thioesterase Itarget
ImidazoleA/G-specific adenine glycosylasetarget
ImidazoleYopE regulatortarget
ImidazoleUnconventional myosin-Ietarget
ImidazoleMeiotic recombination protein DMC1/LIM15 homologtarget
ImidazoleGuanine deaminasetarget
ImidazoleEndo-1,4-beta-xylanase Atarget
ImidazoleBacterial hemoglobintarget
ImidazoleMolybdenum cofactor biosynthesis protein Btarget
ImidazoleUracil-DNA glycosylase inhibitortarget
ImidazoleRecombination protein RecRtarget